ViaDerma, Inc. Stock News
$0.0055
-0.0005 (-8.33%)
At Close: Jun 14, 2024
ViaDerma Provides Highlights of Quarterly Financial Report
08:00am, Thursday, 06'th Jun 2024
LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce that on May 13, 2024, the Company released its quarterly report for the period ending March 31, 20
ViaDerma Update on Stability Testing, Global Sales Distribution, National Licensing, Nupelo & More
10:30am, Tuesday, 24'th Oct 2023
LOS ANGELES, Calif., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM) is pleased to announce several new and exciting business updates for current and prospective shareholders, custom
ViaDerma, Inc. Set to Launch Two New and Improved Versions of its Flagship Product, Vitastem and Vitastem Ultra
05:00am, Monday, 04'th Oct 2021
LOS ANGELES, Oct. 04, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) is pleased to announce they are launching two new and improved formulas for its top selling product, Vit
ViaDerma, Inc. Files Amended Financial Statements
10:23am, Tuesday, 24'th Aug 2021
LOS ANGELES, Aug. 24, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM) published a Quarterly Report for the three months ended March 31, 2021, on the OTC Markets website repor
ViaDerma, Inc. Provides Updates on Current Business Activities
05:00am, Thursday, 24'th Jun 2021
The Company has finalized a ten-year $12 million licensing agreement with a Dubai Company The Company has finalized a ten-year $12 million licensing agreement with a Dubai Company
ViaDerma, Inc. Announces Expansion of its Current Licensing Agreement and Provides Additional Company Updates
05:00am, Wednesday, 02'nd Jun 2021
Dr. Chris Otiko will be traveling to Dubai this month to finalize a 10-year, $12 million contract Dr. Chris Otiko will be traveling to Dubai this month to finalize a 10-year, $12 million contract
ViaDerma, Inc. Nearing Initial Order from Large Hospital Network
05:00am, Thursday, 13'th May 2021
LOS ANGELES, May 13, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announced they are nearing the end of their discussions with a major healthcare network to finalize an i
ViaDerma, Inc. Provides Preliminary Revenue Estimates and Highlights for its Record Breaking 1st Quarter
05:00am, Thursday, 08'th Apr 2021
The Company realized significant Q1 revenue growth due to increased online retail sales and proceeds from a licensing agreement The Company realized significant Q1 revenue growth due to increased onli
ViaDerma, Inc. Announces the Payment of all Toxic Convertible Notes and Has Become Debt Free
05:00am, Tuesday, 16'th Mar 2021
The Company expects to completely self-fund all operations going forward The Company expects to completely self-fund all operations going forward
ViaDerma, Inc. Completes a Licensing Agreement with a Group of Affiliate Wound Care Medical Practices Operating in Six States
05:00am, Thursday, 21'st Jan 2021
LOS ANGELES, Jan. 21, 2021 (GLOBE NEWSWIRE) -- ViaDerma, Inc., (“Company”) (OTC Pink: VDRM), announces the completion of a licensing agreement with a group of affiliated wound care medical practic
VDRM Stock: 13 Things to Know as Penny Stock ViaDerma Rockets 1,000%
04:06pm, Wednesday, 13'th Jan 2021
VDRM stock is skyrocketing on Wednesday after ViaDerma released its outlook for 2021. Here's what penny stock investors should know now.
